Sumoylation of Specificity Protein 1 Augments Its Degradation by Changing the Localization and Increasing the Specificity Protein 1 Proteolytic Process

Journal of Molecular Biology

Volumn 380, Issue 5, 2008, Pages 869-885

  Wang, Yi Ting ^a   Chuang, Jian Ying ^a   Shen, Meng Ru ^a   Yang, Wen Bin ^a   Chang, Wen Chang ^a   Hung, Jan Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

cervical cancer; rpt6; Sp1; sumoylation; ubiquitination

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; HEMAGGLUTININ; MYC PROTEIN; PROTEIN SUBUNIT; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SUMOYLATION; UBIQUITINATION; UTERINE CERVIX CANCER;

EID: 45849120181     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.05.043     Document Type: Article

References (48)

1. Kadonaga J.T., Carner K.R., Masiarz F.R., and Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51 (1987) 1079-1090
2. Black A.R., Black J.D., and Azizkhan-Clifford J. Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188 (2001) 143-160
3. Li L., He S., Sun J.M., and Davie J.R. Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 82 (2004) 460-471
4. Chang W.C., and Chen B.K. Transcription factor Sp1 functions as an anchor protein in gene transcription of human 12(S)-lipoxygenase. Biochem. Biophys. Res. Commun. 338 (2005) 117-121
5. Bouwman P., and Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol. Cell. Endocrinol. 195 (2002) 27-38
6. Hung J.J., Wang Y.T., and Chang W.C. Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol. Cell. Biol. 26 (2006) 1770-1785
7. Spengler M.L., and Brattain M.G. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription. J. Biol. Chem. 281 (2006) 5567-5574
8. Armstrong S.A., Barry D.A., Leggett R.W., and Mueller C.R. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 272 (1997) 13489-13495
9. Jackson S., Gottlieb T., and Hartley K. Phosphorylation of transcription factor Sp1 by the DNA-dependent protein kinase. Adv. Second Messenger Phosphoprotein Res. 28 (1993) 279-286
10. Han I., and Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17 (1997) 2550-2558
11. Su K., Roos M.D., Yang X., Han I., Paterson A.J., and Kudlow J.E. An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J. Biol. Chem. 274 (1999) 15194-15202
12. 2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol. Biol. Cell 19 (2008) 1139-1151
13. Su K., Yang X., Roos M.D., Paterson A.J., and Kudlow J.E. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem. J. 348 Pt 2 (2000) 281-289
14. Satoh K., Sasajima H., Nyoumura K.I., Yokosawa H., and Sawada H. Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. Biochemistry 40 (2001) 314-319
15. Zhang F., Hu Y., Huang P., Toleman C.A., Paterson A.J., and Kudlow J.E. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J. Biol. Chem. 282 (2007) 22460-22471
16. Hay R.T. Protein modification by SUMO. Trends Biochem. Sci. 26 (2001) 332-333
17. Owerbach D., McKay E.M., Yeh E.T., Gabbay K.H., and Bohren K.M. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem. Biophys. Res. Commun. 337 (2005) 517-520
18. Wohlschlegel J.A., Johnson E.S., Reed S.I., and Yates III J.R. Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem. 279 (2004) 45662-45668
19. Seeler J.S., and Dejean A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4 (2003) 690-699
20. Verger A., Perdomo J., and Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4 (2003) 137-142
21. Everett R.D., Lomonte P., Sternsdorf T., van Driel R., and Orr A. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112 Pt 24 (1999) 4581-4588
22. Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., and Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275 (2000) 13321-13329
23. Desterro J.M., Rodriguez M.S., and Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2 (1998) 233-239
24. Hilgarth R.S., Hong Y., Park-Sarge O.K., and Sarge K.D. Insights into the regulation of heat shock transcription factor 1 SUMO-1 modification. Biochem. Biophys. Res. Commun. 303 (2003) 196-200
25. Hietakangas V., Ahlskog J.K., Jakobsson A.M., Hellesuo M., Sahlberg N.M., Holmberg C.I., et al. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23 (2003) 2953-2968
26. Gill G. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr. Opin. Genet. Dev. 13 (2003) 108-113
27. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15 (2005) 536-541
28. Le Drean Y., Mincheneau N., Le Goff P., and Michel D. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143 (2002) 3482-3489
29. Bies J., Markus J., and Wolff L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277 (2002) 8999-9009
30. Hosoi Y., Watanabe T., Nakagawa K., Matsumoto Y., Enomoto A., Morita A., et al. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int. J. Oncol. 25 (2004) 461-468
31. Dynan W.S., and Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35 (1983) 79-87
32. Dynan W.S., and Tjian R. Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 32 (1983) 669-680
33. Taatjes D.J., Naar A.M., Andel III F., Nogales E., and Tjian R. Structure, function, and activator-induced conformations of the CRSP coactivator. Science 295 (2002) 1058-1062
34. Sugawara T., Nomura E., Nakajima A., and Sakuragi N. Characterization of binding between SF-1 and Sp1: predominant interaction of SF-1 with the N-terminal region of Sp1. J. Endocrinol. Invest. 27 (2004) 133-141
35. 3. Oncogene 23 (2004) 4856-4861
36. WAF1/CIP1 promoter. J. Biol. Chem. 278 (2003) 36496-36504
37. Kang H.T., Ju J.W., Cho J.W., and Hwang E.S. Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J. Biol. Chem. 278 (2003) 51223-51231
38. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., and Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl Acad. Sci. USA 98 (2001) 6611-6616
39. Ye X., and Liu S.F. Lipopolysaccharide causes Sp1 protein degradation by inducing a unique trypsin-like serine protease in rat lungs. Biochim. Biophys. Acta. 1773 (2007) 243-253
40. Prudden J., Pebernard S., Raffa G., Slavin D.A., Perry J.J., Tainer J.A., et al. SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26 (2007) 4089-4101
41. Sun H., Leverson J.D., and Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 26 (2007) 4102-4112
42. Deniaud E., Baguet J., Mathieu A.L., Pages G., Marvel J., and Leverrier Y. Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 25 (2006) 7096-7105
43. Kanai M., Wei D., Li Q., Jia Z., Ajani J., Le X., et al. Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin. Cancer Res. 12 (2006) 6395-6402
44. Honda H., Pazin M.J., Ji H., Wernyj R.P., and Morin P.J. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J. Biol. Chem. 281 (2006) 21433-21444
45. Lou Z., O'Reilly S., Liang H., Maher V.M., Sleight S.D., and McCormick J.J. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res. 65 (2005) 1007-1017
46. Higgins K.J., Abdelrahim M., Liu S., Yoon K., and Safe S. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. Biochem. Biophys. Res. Commun. 345 (2006) 292-301
47. Shi Q., Le X., Abbruzzese J.L., Peng Z., Qian C.N., Tang H., et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61 (2001) 4143-4154
48. WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene 19 (2000) 3766-3773